Antibodies and Antibody Drug Conjugates
09.04.2018 - 10.04.2018
Copthorne Tara Hotel,
Scarsdale Place, Kensington,
W8 5SY London, Großbritannien
Antibodies and antibody drug conjugates (ADCs) have the potential to make a ground-breaking impact upon medicinal therapies, diagnostics and characterization of diseases. There is massive potential for ADCs to be used in the development of targeted solid tumour therapies, due to their ability to act as precisely and effectively on target antigens.
Join us this April 2018, as SMi's ADC Summit conference brings together industry experts from leading life science and pharmaceutical companies.
Standard Price (early-bird rates available): GBP 1499
Alle mit einem Stern * versehenen Felder sind Pflichtfelder!